These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8269182)

  • 1. The use of angiotensin-converting enzyme inhibitors in the treatment and prevention of congestive heart failure.
    Toher CA; Francis GS
    Coron Artery Dis; 1993 Jan; 4(1):37-43. PubMed ID: 8269182
    [No Abstract]   [Full Text] [Related]  

  • 2. Practical issues for the use of ACE inhibitors in acute myocardial infarction.
    Testa M; Sonnenblick EH; Lejemtel TH
    J Cardiovasc Risk; 1995 Oct; 2(5):429-33. PubMed ID: 8749270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [ACE inhibitors early after myocardial infarct].
    Heinzl S
    Med Monatsschr Pharm; 1994 Jul; 17(7):197. PubMed ID: 8090131
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current aspects of ACE inhibitor therapy from the cardiologic viewpoint].
    Klein W; Eber B; Gasser R; Stoschitzky K; Schumacher M; Fruhwald FM; Zweiker R
    Wien Med Wochenschr; 1996; 146(11):221-4. PubMed ID: 8928518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Angiotensin-converting enzyme inhibitors in the treatment of heart failure: toward a change in the natural history of the disease].
    Martín Luengo C; Arribas Jiménez A; Nieto Ballestero F; Diego Domínguez M; Cascón Bueno M; Pabón Osuna P; Sala Sánchez-Castillo A
    Rev Esp Cardiol; 1993 Mar; 46(3):131-45. PubMed ID: 8488316
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of congestive heart failure by ACE inhibition in patients with acute myocardial infarction.
    Sigurdsson A; Swedberg K
    J Cardiovasc Risk; 1995 Oct; 2(5):406-12. PubMed ID: 8749267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current role of digoxin in the treatment of heart failure.
    Smith JR; Gheorghiade M; Goldstein S
    Coron Artery Dis; 1993 Jan; 4(1):16-26. PubMed ID: 8269181
    [No Abstract]   [Full Text] [Related]  

  • 8. [The use of angiotensin-converting enzyme inhibitors in anterior infarct without congestive symptoms. The arguments pro].
    de Teresa E
    Rev Esp Cardiol; 1994 Nov; 47(11):723-8. PubMed ID: 7800901
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of angiotensin-converting enzyme inhibitors in anterior infarct without congestive symptoms. The arguments contra].
    Rodríguez Lambert JL; Moris C
    Rev Esp Cardiol; 1994 Nov; 47(11):719-22. PubMed ID: 7800900
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin converting enzyme inhibition therapy following myocardial infarction. Rationale for clinical trials.
    Pfeffer MA
    Herz; 1991 Sep; 16 Spec No 1():278-82. PubMed ID: 1840297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical background to the use of ACE inhibitor therapy after myocardial infarction.
    Hall AS; Ball SG
    J Cardiovasc Risk; 1995 Oct; 2(5):396-405. PubMed ID: 8749266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE inhibitors: myocardial infarction and congestive heart failure.
    Cody RJ
    Am Fam Physician; 1995 Nov; 52(6):1801-6. PubMed ID: 7484690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rational therapy of heart failure].
    Werner MG; Schmieder RE
    Z Kardiol; 1993; 82 Suppl 4():7-16. PubMed ID: 8147063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications for immediate angiotensin-converting enzyme inhibition in patients with acute myocardial infarction.
    LeJemtel TH; Hochman JS; Sonnenblick EH
    J Am Coll Cardiol; 1995 Jun; 25(7 Suppl):47S-51S. PubMed ID: 7775715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitors: congestive heart failure and beyond.
    Lombardi WL; Litwin SE
    Coron Artery Dis; 1999 Sep; 10(6):361-8. PubMed ID: 10474785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary prevention: improving outcomes following myocardial infarction.
    Maggioni AP
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i5-7:discussion i50. PubMed ID: 10956310
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurohormonal activation and congestive heart failure: today's experience with ACE inhibitors and rationale for their use.
    Sigurdsson A; Swedberg K
    Eur Heart J; 1995 Dec; 16 Suppl N():65-72. PubMed ID: 8682064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of angiotensin-converting enzyme inhibitors in myocardial infarction and congestive heart failure: implications for clinical practice.
    Pitt B
    Cardiology; 1995; 86 Suppl 1():41-5. PubMed ID: 7614506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasodilator therapy for congestive heart failure. Lessons from mortality trials.
    Groden DL
    Arch Intern Med; 1993 Feb; 153(4):445-54. PubMed ID: 8435024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of ACE inhibitors in heart failure (clinical aspects)].
    Riegger AJ
    Z Kardiol; 1992; 81 Suppl 4():93-6. PubMed ID: 1290309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.